Rheumatoid Arthritis News

    Skip to content
    • Home
    • Treatments
      • Tofacitinib (Xeljanz)
    • Experimental Treatments
      • Piclidenoson
      • Kevzara (Sarilumab)
      • Baricitinib (Olumiant)
    • About Us
    • Contact Us
    •
      June 12, 2017August 24, 2022

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more
    • June 7, 2017June 7, 2017

      Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more
    • June 5, 2017June 5, 2017

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab), ... Read more
    • June 2, 2017June 2, 2017

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective ... Read more
    • May 23, 2017May 23, 2017

      Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

      Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis ... Read more
    #EULAR 2016 – Repetitive Manual Work Can Increase a Person’s Risk of Developing RA
    June 14, 2016June 14, 2016

    #EULAR 2016 – Repetitive Manual Work Can Increase a Person’s Risk of Developing RA

    News
    Researchers in Sweden report that long-term, repetitive manual work is associated with an increased risk for rheumatoid arthritis (RA). Their study, discussed at the recent European League Against Rheumatism Annual Congress (EULAR 2016) in London, is ... Read more
    #EULAR 2016: UK Rheumatologists Often Prescribe Outside NICE Guidlines
    June 13, 2016June 13, 2016

    #EULAR 2016: UK Rheumatologists Often Prescribe Outside NICE Guidlines

    News
    A study presented at the European League Against Rheumatism Annual Congress (EULAR 2016) revealed that several factors not related to cost might influence the prescription of TNF inhibitors for patients with rheumatoid arthritis (RA). ... Read more
    #EULAR 2016 – Rheumatoid Arthritis Treatment Adherence Improved with Positive Expectations, Information
    June 13, 2016June 13, 2016

    #EULAR 2016 – Rheumatoid Arthritis Treatment Adherence Improved with Positive Expectations, Information

    News
    At the European League Against Rheumatism Annual Congress (EULAR 2016) June 8-11 in London, two new studies offered insights on why patients with rheumatoid arthritis (RA) do not adhere to their treatment ... Read more
    #EULAR 2016 – Counseling and Reminders Help RA Patients to Be More Active
    June 13, 2016June 13, 2016

    #EULAR 2016 – Counseling and Reminders Help RA Patients to Be More Active

    News
    Behavioral interventions that combine text message reminders and counseling sessions to encourage rheumatoid arthritis patients to be more physically active lead to better clinical outcomes, according to a study presented ... Read more
    #EULAR2016 – New Study Could Lead to Test for Personalized RA Treatments
    June 10, 2016June 10, 2016

    #EULAR2016 – New Study Could Lead to Test for Personalized RA Treatments

    News
    New research presented at the European League Against Rheumatism Annual Congress (EULAR 2016) June 8-11 in London could help with the development of personalized treatments for rheumatoid arthritis (RA). Specific ... Read more
    #EULAR2016 – Depression Linked to Adolescent Arthritis Disease Activity and Disability in Nationwide UK Study
    June 10, 2016June 10, 2016

    #EULAR2016 – Depression Linked to Adolescent Arthritis Disease Activity and Disability in Nationwide UK Study

    News
    In a new study, researchers say they have found a clear association between depression and the level of disease activity and disability in adolescent patients with juvenile inflammatory arthritis, the most common ... Read more
    #EULAR2016 – Smoking and Obesity in RA Patients Reduces Chance of Reaching Sustained Remission
    June 10, 2016June 10, 2016

    #EULAR2016 – Smoking and Obesity in RA Patients Reduces Chance of Reaching Sustained Remission

    News
    Smoking and obesity in patients with rheumatoid arthritis (RA) are factors preventing patients from reaching sustained remission, according to findings presented at the European League Against Rheumatism Annual Congress (EULAR 2016) June ... Read more
    #EULAR2016 – Genetic Profiling Could Help Predict Response to Rheumatoid Arthritis Therapy
    June 10, 2016June 10, 2016

    #EULAR2016 – Genetic Profiling Could Help Predict Response to Rheumatoid Arthritis Therapy

    News
    Genetic profiling could be used to predict whether or not patients with rheumatoid arthritis (RA) will respond to treatment, according to two new studies. The results were presented at the ... Read more
    Humira Has Dual Role in Suppressing Inflammation in Rheumatoid Arthritis Patients
    June 9, 2016June 9, 2016

    Humira Has Dual Role in Suppressing Inflammation in Rheumatoid Arthritis Patients

    News
    A new study developed by researchers at the University College London in England has identified a new role for the anti-inflammatory drug Humira (adalimumab) in rheumatoid arthritis (RA): It works ... Read more
    #EULAR2016: Corrona Delivers Novel Research Evidence on Rheumatoid Arthritis
    June 9, 2016June 9, 2016

    #EULAR2016: Corrona Delivers Novel Research Evidence on Rheumatoid Arthritis

    News
    Southborough, Massachusetts-based Corrona LLC, independent specialists in the compilation of real-world evidence and consulting on auto-immune disorders, is represented at EULAR 2016 — the Annual European Congress of Rheumatology June 8-11 in ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another RA update.

    * indicates required
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • Diplomat selling Kevzara

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      June 12, 2017

    • Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      June 7, 2017

    • Truxima, a biosimilar of rituximab

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      June 5, 2017

    • triple therapy

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      June 2, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.